The effect of professional-led guideline workshops on clinical practice for the management of patent ductus arteriosus in preterm neonates in Japan: a controlled before-and-after study

Table 1 Pre- and post-workshop comparisons of physicians’ PDA management skills

Confidence rating	Pre-WS mean (SD)	Post-WS mean (SD)	pvalue
Prophylactic indomethacin	2.13 (0.99)	2.53 (1.13)	0.14
Treatment of symptomatic PDA	2.20 (0.86)	2.60 (0.99)	0.06
Decision of PDA ligation	1.87 (0.83)	2.40 (0.99)	0.02
Monitoring during indomethacin administration (e.g., signs and complications)	2.60 (0.91)	2.73 (0.80)	0.41
Other PDA treatments (e.g., transfusion, diuretics)	2.00 (0.76)	2.33 (0.82)	0.03
PDA treatments in chronic phase	1.87 (0.99)	2.20 (0.77)	0.21
Fluid management during PDA treatments	2.20 (0.94)	2.47 (0.83)	0.16
Respiratory management during PDA treatments	2.13 (0.74)	2.47 (0.83)	0.06
Nutrition during PDA treatments	2.27 (0.88)	2.47 (0.99)	0.32
Overall	2.14 (0.76)	2.47 (0.80)	0.02
Sheffield Peer Review Assessment Tool
Good clinical care	4.11 (0.56)	4.49 (0.76)	0.03
Maintain good medical practice	3.95 (0.52)	4.36 (0.77)	0.03
Teaching and training	4.10 (0.99)	4.43 (0.92)	0.04
Relationship with patients	4.67 (0.77)	4.89 (0.97)	0.08
Working relationships with colleagues	4.13 (0.36)	4.43 (0.73)	0.09
Overall	4.14 (0.42)	4.50 (0.71)	0.05

Wilcoxon signed-rank test was used, and p value <0.05 was considered statistically significant. There were no missing data. Pre-WS: before the workshops; Post-WS: after the workshops; 95% CI: confidence interval; confidence rating score range: 1 to 4; Sheffield Peer Review Assessment Tool score range: 1 to 6

ISSN: 1748-5908